GlassScriptPhysician profile
Ebony Gaffney
NPI 1184851958
$2,615.16
in general payments reported to CMS, 2019-2025
15 companies · $727 in 2025
The $727 reported for 2025 was more than what 76% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.60 · 2020: $30.19 · 2021: $253 · 2022: $505 · 2023: $604 · 2024: $406 · 2025: $727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,737.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,737.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $480.98 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $371.21 | 2024-2025 | Cobenfy |
| Alkermes, INC. | $369.36 | 2021-2025 | Aristada, Lybalvi |
| Janssen Pharmaceuticals, INC | $322.90 | 2020-2025 | Invega Sustenna, Invega Trinza |
| Teva Pharmaceuticals USA, INC. | $238.88 | 2022-2025 | Austedo Xr, Austedo, Uzedy |
| Otsuka America Pharmaceutical, INC. | $179.15 | 2021-2025 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Neurocrine Biosciences, INC. | $160.57 | 2021-2025 | Ingrezza |
| Vanda Pharmaceuticals INC. | $125.46 | 2021-2025 | Fanapt, Hetlioz |
| Novartis Pharmaceuticals Corporation | $90.60 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $89.24 | 2021-2025 | Caplyta |
| Lundbeck LLC | $60.93 | 2022 | |
| Corium, LLC | $59.26 | 2022-2023 | Azstarys |
| Sunovion Pharmaceuticals INC. | $32.56 | 2021 | |
| Axsome Therapeutics, INC. | $17.76 | 2025 | Auvelity |
| Indivior INC. | $16.30 | 2023 | Perseris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ebony Gaffney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.